Top 10 health stories of 2004.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D000928:Antidepressive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000627:therapeutic use; D035843:Biomedical Research; D008078:Cholesterol, LDL / Q000097:blood; D019976:Cloning, Organism; D003327:Coronary Disease / Q000175:diagnosis; D003695:Delivery of Health Care; D003704:Dementia / Q000517:prevention & control; D000077156:Gefitinib; D006801:Humans; D007252:Influenza Vaccines / Q000600:supply & distribution; D007348:Insurance, Health / Q000191:economics; D007783:Lactones / Q000009:adverse effects; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis; D011799:Quinazolines / Q000627:therapeutic use; D012042:Registries; D013450:Sulfones / Q000009:adverse effects; D016138:Walking
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000924:Anticholesteremic Agents; D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D008078:Cholesterol, LDL; D007252:Influenza Vaccines; D007783:Lactones; D011799:Quinazolines; D013450:Sulfones; C116926:rofecoxib; D017430:Prostate-Specific Antigen; D000077156:Gefitinib